Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |